| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/22/2004 | WO2004007537A2 Modified adenoviral fiber with ablated to cellular receptors |
| 01/22/2004 | WO2004007531A2 Activated checkpoint therapy and methods of use thereof |
| 01/22/2004 | WO2004007020A2 Thermotherapy method for treatment and prevention of breast cancer and cancer in other organs |
| 01/22/2004 | WO2004006961A1 Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors |
| 01/22/2004 | WO2004006949A1 Methods and compositions for regulation of mammalian hair growth |
| 01/22/2004 | WO2004006893A1 Method for particle precipitation using near-critical and supercritical antisolvents |
| 01/22/2004 | WO2004006866A2 Antifungal therapeutic targets |
| 01/22/2004 | WO2004006853A2 Treatment and prophylaxis with 4-1bb-binding agents |
| 01/22/2004 | WO2004006839A2 Pituitary adenylate cyclase activating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use |
| 01/22/2004 | WO2004006831A2 Method and device for inducing biological processes by micro-organs |
| 01/22/2004 | WO2004006678A1 Spliceosome mediated rna trans-splicing for correction of skin disorders |
| 01/22/2004 | WO2003097107A3 Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier |
| 01/22/2004 | WO2003090778A3 Dna vaccine combined with an inducer of tumor cell apoptosis |
| 01/22/2004 | WO2003078595A3 Immunostimulatory double stranded rna and methods of inducing, enhancing or modulating the immune response |
| 01/22/2004 | WO2003066087A3 Kinases involved in the regulation of energy homeostasis |
| 01/22/2004 | WO2003059381A3 Immunogenic preparations and vaccines on the basis of mrna |
| 01/22/2004 | WO2003048205A3 Novel proteins with il-6 inhibiting activity |
| 01/22/2004 | WO2003045316A3 Polynucleotide therapy |
| 01/22/2004 | WO2003027251A3 Novel molecules of the pyrin domain protein family and uses thereof |
| 01/22/2004 | WO2003008595A3 Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression |
| 01/22/2004 | US20040016013 Achieves widespread distribution, systemic expression and sustained delivery in the animal; oral gene therapy |
| 01/22/2004 | US20040016006 Chromosome 3p21.3 genes are tumor suppressors |
| 01/22/2004 | US20040014956 For increasing nuclease resistance of antisense sequences |
| 01/22/2004 | US20040014757 Method for the treatment or prevention of viral infection using nucleoside analogues |
| 01/22/2004 | US20040014709 Genetic engineered adenoviral vector coding interferon gene; therapy against bladder cancer |
| 01/22/2004 | US20040014705 Supplying polypeptides; coupling with controller; therapy for autoimmune disease |
| 01/22/2004 | US20040014704 Reducing immunology response; sustained release |
| 01/22/2004 | US20040014701 Inhibiting retrotransposon and retroviral integration by targeting the atm pathway |
| 01/22/2004 | US20040014700 Novel oligonucleotides and use of oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments, as depigmentation agents |
| 01/22/2004 | US20040014699 Antisense modulation of PTPRM expression |
| 01/22/2004 | US20040014698 Oral administration of therapeutic agent coupled to transporting agent |
| 01/22/2004 | US20040014668 Human NK3-related prostate specific gene 1 |
| 01/22/2004 | US20040014664 Analyzing tumors; bone disorders; antidiabetic agents; platelet derived endothelial growth factor |
| 01/22/2004 | US20040014656 Method for diagnosing neuronal deseases and for treating primary hemostasis deficiency |
| 01/22/2004 | US20040014645 Increased delivery of a nucleic acid construct in vivo by the poly-L-glutamate ("PLG") system |
| 01/22/2004 | US20040014220 Using electroporation to transfer nucleotide sequences and biologicaly active molecules into peripheral human blood cells; gene therapy |
| 01/22/2004 | US20040014192 PR/SET-domain containing nucleic acids, polypeptides, antibodies and methods of use |
| 01/22/2004 | US20040014191 Comprises nucleotide sequences and viral vector coding nitroreductase for generating cytotoxic 4- hydroxylamine to treat cancer; site diredted mutagenesis; prodrugs; anticarcinogenic agents |
| 01/22/2004 | US20040014187 Comprises genetically engineered protease for treatment tumors; gene therapy |
| 01/22/2004 | US20040014174 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same |
| 01/22/2004 | US20040014171 Soluble CTLA4 mutant molecules and uses thereof |
| 01/22/2004 | US20040014113 Method for efficient RNA interference in mammalian cells |
| 01/22/2004 | US20040014111 Methods for the identification of IKKalpha function and other genes useful for treatment of imflammatory diseases |
| 01/22/2004 | US20040014110 Dendritic enriched secreted lymphocyte activation molecule |
| 01/22/2004 | US20040014057 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
| 01/22/2004 | US20040014055 Gene coding for erbin, and diagnostic and therapeutic uses thereof |
| 01/22/2004 | US20040014049 Used for treatment of diseases associated with expression of protein kinase C-iota ; cancer |
| 01/22/2004 | US20040014048 Antisense modulation of dual specific phosphatase 6 expression |
| 01/22/2004 | US20040014047 LIM is an acronym for 3 gene products Lin-11, Isl-1 and Mec-3 (it is a serine/threonine kinase); oligonucleotides that specifically hybridizable with nucleic acids encoding LIM domain kinase 1 |
| 01/22/2004 | US20040014037 Release factors (RF-1) polypeptides and DNA (RNA) encoding RF-1 polypetides and methods for producing such polypeptides by recombinant techniques; utilizing RF-1 polypeptides to screen for antibiotics |
| 01/22/2004 | US20040013740 Antitumor agents for treating tumor of mucosa, skin; poisons are selected from scolopenders, snakes, spiders or scorpions |
| 01/22/2004 | US20040013719 Regulation of cell proliferation and differentiation using topically applied nucleric acid molecules |
| 01/22/2004 | US20040013691 Immunotoxin as a therapeutic agent and uses thereof |
| 01/22/2004 | US20040013677 Mixtures; for therapy, prevention; purity polypeptide |
| 01/22/2004 | US20040013668 Polypeptide antibody which binds to low density lipoprotein; quantitative analysis |
| 01/22/2004 | US20040013662 Microbubble compositions and methods for oligonucleotide delivery |
| 01/22/2004 | US20040013658 Method of inducing apoptosis by reducing the level of thiamin |
| 01/22/2004 | US20040013657 Novel nucleic acids and polypeptides |
| 01/22/2004 | US20040013655 Mutant Dna; transcription of genomes |
| 01/22/2004 | US20040013653 Stimulation of angiogenesis via enhanced endothelial expression of syndecan-4 core proteins |
| 01/22/2004 | US20040013650 Adjust concentration of circulating genes; in situ transformation of muscle by injecting virus vector |
| 01/22/2004 | US20040013648 Vector system |
| 01/22/2004 | US20040013645 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 01/22/2004 | US20040013573 Used to synthesize nucleic acid arrays |
| 01/22/2004 | CA2494245A1 Methods of making viral particles having a modified cell binding activity and uses thereof |
| 01/22/2004 | CA2493675A1 Genes |
| 01/22/2004 | CA2493111A1 Diagnosis and prevention of cancer cell invasion |
| 01/22/2004 | CA2492772A1 Activated checkpoint therapy and methods of use thereof |
| 01/22/2004 | CA2492716A1 Brachyspira hyodysenteriae vaccine |
| 01/22/2004 | CA2492561A1 Treatment and prophylaxis with 4-1bb-binding agents |
| 01/22/2004 | CA2492469A1 Spliceosome mediated rna trans-splicing for correction of skin disorders |
| 01/22/2004 | CA2492355A1 Method for diagnosis of intestinal-type gastric tumors |
| 01/22/2004 | CA2491924A1 Thermotherapy method for treatment and prevention of breast cancer and cancer in other organs |
| 01/22/2004 | CA2491805A1 Modified adenoviral fiber with ablated binding to cellular receptors |
| 01/22/2004 | CA2491279A1 Pituitary adenylate cyclase activating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use |
| 01/22/2004 | CA2491235A1 Chromosome 3, 5 and 11 genes involved in premature canities |
| 01/22/2004 | CA2491223A1 Chromosome 6 and 9 genes involved in premature canities |
| 01/22/2004 | CA2489174A1 Rna-interference by single-stranded rna molecules |
| 01/21/2004 | EP1382969A1 Diagnosis and prevention of cancer cell invasion |
| 01/21/2004 | EP1382688A1 Screening method |
| 01/21/2004 | EP1382679A2 Vascular Endothelial Growth Factor Related Protein (VRP) Antagonists |
| 01/21/2004 | EP1382616A2 Pharmaceutical composition for use in the treatment of abnormalities associated with the activity of a human Y5-receptor |
| 01/21/2004 | EP1381867A2 Method for evaluating the efficacy of treatment with bacterial dna and bacterial cell walls |
| 01/21/2004 | EP1381686A2 Inactivation of genes of the mep pathway |
| 01/21/2004 | EP1381684A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/21/2004 | EP1381629A2 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN |
| 01/21/2004 | EP1381410A2 Methods of isolating blood components using a centrifuge and uses thereof |
| 01/21/2004 | EP1381393A1 Microparticle protection of therapeutic agents |
| 01/21/2004 | EP1381390A2 Multivalent vaccine comprising an hiv antigen and an hsv antigen and/or an hpv antigen |
| 01/21/2004 | EP1381280A1 Viral vectors and their use in therapeutic methods |
| 01/21/2004 | EP1381276A2 Method of treating or retarding the development of blindness |
| 01/21/2004 | EP1191942B1 Use of antileukoprotease for the treatment of endometriosis |
| 01/21/2004 | EP0977596B1 Use of papovavirus capsid protein for delivery of therapeutic agents to neuronal cells |
| 01/21/2004 | EP0516664B1 Transgenic animals, cells and cell lines therefrom, and their use |
| 01/21/2004 | CN1469759A Implants with a phosphazene-containing coating |
| 01/21/2004 | CN1469756A Novel drugs for liver diseases |
| 01/21/2004 | CN1469755A Vaccines containing ribavirin and methods of use thereof |
| 01/20/2004 | US6680424 Modified proteinase inhibitors |
| 01/20/2004 | US6680375 Antibody for use in the diagnosis, treatment and prevention of bone disorders and cancer |
| 01/20/2004 | US6680373 Polypeptide for use in the human diagnostics and therapeutics |